Navigation Links
Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems
Date:3/11/2009

Only Radiotherapy Department in State of Qatar to Introduce State-of-the-Art Treatments including RapidArc(TM) Technology

DOHA, Qatar, March 11 /PRNewswire-FirstCall/ -- One of the leading cancer centers in the Middle East has acquired two advanced radiotherapy devices from Varian Medical Systems (NYSE: VAR) equipped with RapidArc(TM) technology for fast and precise treatments. Al Amal Hospital in Doha, Qatar, is replacing four-year-old linear accelerators from another manufacturer with Trilogy(R) and Clinac(R) iX devices, in order to provide patients with more modern and efficient treatments.

The new equipment, ordered in February and scheduled to be installed in May, will enable clinicians in Qatar's only radiation therapy center to begin treatments using RapidArc, Varian's latest technology for delivering image-guided intensity-modulated radiotherapy (IMRT) with greater precision and up to eight times faster than is possible with conventional IMRT.

Dr. Noora Mohammed Al-Hammadi, head of the department of radiation oncology, said, "Evidence suggests that RapidArc will revolutionize the way IMRT is delivered and potentially improve patient outcomes. Faster treatment that more closely conform radiation doses to the size, shape and location of the tumor are always desirable in radiotherapy, for both machine throughput as well as patient outcomes. We are very excited about the potential of RapidArc."

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the medical linear accelerator around the patient. Varian's Clinac and Trilogy accelerators can target beams at a tumor while continuously rotating around the patient. Conventional IMRT treatments are slower for radiotherapists because they use many fixed angle beams rather than a continuous rotational beam.

Part of the Hamad Medical Corporation, the government provider of health in the State of Qatar, Al Amal Hospital treats patients from across the Gulf region. Its patients represent a complex mix of all types of tumors, including pediatric cases and a large proportion of breast cancer patients. The department aims to become a recognized Centre of Excellence in image-guided radiotherapy (IGRT) for the region within five years.

"This is the vision and we are already well on our way," says Dr Al-Hammadi. "We have always ensured that the treatments offered to the population of Qatar match those found in any major state-of-the-art cancer center in the world. In keeping with this mandate, we evaluated offerings from all three major vendors, as well as other arc therapy techniques such as helical tomotherapy, and decided that Varian had the most advanced systems and the most clinically integrated system to meet our needs."

"Varian's equipment and software supports our belief in seamless care. The ability to implement both RapidArc and stereotactic radiosurgery using 3D image guidance will allow us to offer better precision. In addition, the ARIA(TM) oncology information management system will enable us to go paperless and be fully integrated to the hospital's imaging systems, meaning better workflow and better overall patient care."

Michael Sandhu, head of Varian's Oncology Systems business in the EMEA region, said, "This decision by one of the foremost radiotherapy departments in the Middle East shows that what's most important for customers in this region is not just the latest, most up-to-date technology but also equipment performance and reliability, along with a strong service and support organization in the Gulf region. A huge plus for Varian is our service office and bonded warehouse facility in Bahrain. We have 18 service people including dedicated IT service personnel in the region and they are on hand to provide fast support for local customers."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Trusted LASIK Surgeons Welcomes Leading Laser Expert and Inventor Jon Dishler, M.D., to Its Unique LASIK Eye Surgeon Directory for Consumers
2. Canadian Government Announces Funding for Leading Biotechnology Firms Project
3. PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting
4. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading
5. InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
6. West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists
7. SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London
8. Leading Canadian Scientist to speak at UN Climate Change Conference
9. TRIDELITY Display Solutions Partners With Two Of The World's Leading Imaging Software Companies
10. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... the results of its 2016 Annual General Meeting, which was ... China . At the Annual ... of KPMG Huazhen LLP as the independent auditors of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Lajollacooks4u, San Diego’s premier team building ... team building events, new program offerings and company expansion. , This is ... to include groups of over 30 people. Ever since, Lajollacooks4u has seen significant demand ...
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... OXFORD, England , December 8, 2016 ... Company, has expanded its customisable SureSeq™ NGS panel range with ... - allowing fast and cost-effective study of variants in familial ... copy number variation (CNV) detection on a single small panel ... and hotspot content. This includes all exons for LDLR ...
Breaking Biology Technology:
(Date:11/30/2016)... 2016  higi SH llc (higi) announced today ... national brands, industry thought-leaders and celebrity influencers looking ... for taking steps to live healthier, more active ... higi has built the largest self-screening health station ... people who have conducted over 185 million biometric ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):